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A BST R AC T   
 
Aim: The triglyceride / HDL cholesterol (TG/HDL-c) ratio is increased in a variety of diseases including, 
coronary heart disease and type 2 diabetes mellitus. However, its role in non-alcoholic hepatosteatosis is not 
well understood. In present study, we aimed to compare the TG/HDL-c levels of the patients with non-
alcoholic hepatosteatosis to those of the healthy subjects. 
Methods: Medical data of the patients with non-alcoholic hepatosteatosis whom presented to the outpatient 
internal medicine clinics of our institution were retrospectively analyzed. Healthy subjects whom admissions 
to our clinics were due to check up were enrolled to the study as control group. TG/HDL-c of the groups 
compared. 
Results: TG/HDL-c level of the liver steatosis group (5 (2-22) %) was higher than the control group (2.7 (1-
8) %), (p<0.001). TG/HDL-c was significantly and positively correlated with fasting blood glucose (r=0.31, 
p<0.001), C - reactive protein (r=0.25, p<0.001) and LDL-cholesterol (r=0.3, p<0.001) levels. A TG/HDL-c 
value greater than 3.1% has 91% sensitivity and 77% specificity in detecting hepatosteatosis.  
Conclusions: We suggest that TG/HDL-c ratio could be a useful marker of non-alcoholic hepatosteatosis due 
to its inexpensive and easy to assess nature.  
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Introduction 
Liver steatosis, as known as hepatosteatosis, is 
defined as abnormal lipid accumulation in liver 
cells. The pathogenesis of the hepatosteatosis 
includes inflammation, metabolic disorder and 
hyperlipidemia. Possible contributing factors to 
non-alcoholic hepatosteatosis are metabolic 
syndrome, dyslipidemia, obesity, type 2 
diabetes mellitus and insulin resistance.  
Recent researches studied numerous 
inflammatory and metabolic indices in patients 
with non-alcoholic hepatosteatosis. These 
include; C - reactive protein, mean platelet 
volume, platelet distribution width, mean 
platelet volume to platelet count ratio and 
neutrophil/lymphocyte ratio [1-5]. Novel 
studies pointed out the relationship between 
triglyceride/ HDL cholesterol (TG/HDL-c) 
ratio in various conditions. Elevated TG/HDL-
c level was considered as a risk factor for 
coronary heart disease in male population [6]. 
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In a study from Japan, authors introduced 
TG/HDL-c ratio as a useful tool in predicting 
small LDL particles [7]. Moreover, it has been 
suggested that increased TG/HDL-c levels in 
young adults may serve as a predictor of insulin 
resistance and higher cardiometabolic risk [8].  
In present study, we aimed to compare the 
TG/HDL-c levels of the patients with non-
alcoholic hepatosteatosis to those of the healthy 
subjects.  
 
Materials and methods 
After receiving ethical approval from the local 
ethics committee (Date and decision no: 
2020/311), medical data of the patients with 
non-alcoholic hepatosteatosis whom presented 
to the outpatient internal medicine clinics of our 
institution between October 2018 and October 
2020 were retrospectively analyzed. Healthy 
subjects whom admissions to our clinics were 
due to check up within the same time period 
were enrolled to the study as control group. 
Exclusion criteria were as follows: hepatitis, 
alcohol consumption, active inflammatory 
diseases, hyperlipidemic syndromes, recent 
infection and those with a history of lipid 
lowering drug use. Hepatosteatosis was 
determined by ultrasound scan.  
Age, gender, body weight, height, fasting blood 
glucose (FBG), serum creatinine, LDL 
cholesterol, HDL cholesterol, triglyceride, 
aspartate and alanine transaminases (AST and 
ALT) and c-reactive protein (CRP) levels were 
obtained and recorded from the institutional 
database and patients’ files. Biochemical 
analyses were held with Architect c8000 
analyzer (Abbott Inc. Lake Forest, IL, USA). 
White blood cell count (WBC), hemoglobin 
(Hb), hematocrit (Htc) and platelet count (plt) 
were also recorded. Automatic analyzer of LH 
780 model of Beckman Coulter device 
(Beckman Coulter Inc.; Bre CA) was used for 
complete blood count analyses. A TG/HDL-c 
level was obtained by the ratio of 
triglyceride/HDL-cholesterol. Body mass index 
is calculated by the division of weight by the 
square of height.  Data of the patients with liver 




Data were analyzed with SPSS software (SPSS 
15.0; SPSS Inc., Chicago, IL, USA). 
Kolmogorov-Smirnov test was used in 
observing the distribution (normal or not) of the 
variables in study and control groups in terms 
of normal analyzed with. Variables with normal 
distribution were compared with independent 
samples t test and expressed as mean ± standard 
deviation (SD). Mann- Whitney U test is used 
in comparison of the variables without normal 
distribution and these variables were expressed 
as median (min.-max.). Chi-square test is used 
in comparison of categorical variables between 
study and control subjects. Correlation between 
studies variables were conducted with 
Pearson’s correlation analysis. Receiver 
Operative Characteristics (ROC) analyze used 
in determination of cut-off values of study 
variables in predicting NAFLD. Statistical 
significance was set when the p value was lower 
than 0.05.  
 
Results  
A total of 496 subjects, 267 in liver steatosis 
and 229 in control group, were enrolled to the 
study.  Mean ages of the liver steatosis and 
control groups were 45.5 ± 12 years and 44 ± 
10 years, respectively (p=0.09). 131 (49%) 
were women and 136 (51%) were men in the 
liver steatosis group whereas 96 (42%) were 
women and 133 (58%) were men in control 
group. Gender of the liver steatosis and control 
groups were not statistically different (p=0.11).  
                                              Kurtkulagi et al / Exp Biomed Res. 2021; 4(3):224-229 
























































































                                               
Figure 1. ROC curves of ALT, fasting glucose, triglyceride, CRP, and THR in determination of liver 
steatosis 
 
Figure 2. Correlations of THR with fasting glucose, LDL- cholesterol and CRP level. 
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The WBC (p=0.11), Hb (p=0.26), Htc  
(p=0.08), PLT (p=0.19), serum creatinine 
(p=0.1) and AST (p=0.54) levels of the liver 
steatosis and control groups were not 
statistically different.   
The ALT (p<0.001), FPG (p<0.001), 
triglyceride (p<0.001), LDL-cholesterol 
(p<0.001) and CRP (p<0.001) levels were 
significantly increased and HDL-cholesterol 
(p<0.001) was significantly decreased in liver 
steatosis group compared to the control 
subjects. TG/HDL-c level of the liver steatosis 
group [5 (2-22) %] was higher than the 
TG/HDL-c level of the control group [2.7 (1-8) 
%], and this difference was statistically 
significant (p<0.001).  
In Roc analysis test, a TG/HDL-c value greater 
than 3.1% have 91% sensitivity and 77% 
specificity in detecting hepatosteatosis, which 
is better than other variables, i.e., ALT, FPG, 
triglyceride and CRP (Figure 1). 
In Pearson’s correlation analysis test, TG/HDL-
c was significantly and positively correlated 
with FPG (r=0.31, p<0.001), CRP (r=0.25, 
p<0.001) and LDL-cholesterol (r=0.3, 
p<0.001) levels (Figure 2).  
 
Discussion 
Main finding of present retrospective study is 
that TG/HDL-c ratio could be a promising 
indicator of liver steatosis in general 
population. Since it has significant correlation 
with inflammatory (CRP) and metabolic (FPG 
and LDL-cholesterol) markers of 
hepatosteatosis, and has stunning sensitivity 
and specificity in determination of the disease, 
it may have substantial utility in clinical 
practice.  
Recent studies in literature focused on the 
usefulness of TG/HDL-c ratio in various 
clinical conditions. Authors suggested the 
TG/HDL-c ratio as a novel prognostic marker 
in patients receiving peritoneal dialysis 
treatment since elevated THR was correlated 
with worse survival in this population [9]. 
Chronic renal insufficiency, like liver steatosis, 
is a condition characterized with increased 
inflammatory burden. Therefore, increased 
levels of TG/HDL-c were noted in patients with 
liver steatosis compared to controls in present 
work.  
The role of TG/HDL-c ratio has been studied in 
gestational diabetes mellitus, too. A Chinese 
study reported that elevated first trimester 
TG/HDL-c levels could predict the 
development of gestational diabetes mellitus 
[10]. Both pregnancy, and gestational diabetes 
mellitus are characterized with insulin 
resistance and increased inflammation. Liver 
steatosis is also associated with insulin 
resistance and increased inflammatory burden. 
Therefore, elevated TG/HDL-c levels which 
reported in our study is a compatible finding 
with current medical literature.  
Increased level of TG/HDL-c has been found to 
be a risk factor for inflammatory breast cancer 
in Schairer et al’s study, which reported a 1.7 
odds ratio for the THR level greater than 2.5% 
[11]. Cancer is also promoted by inflammatory 
reactions and cause chronic, low grade, 
continuous inflammatory load. Therefore, as an 
inflammatory condition, liver steatosis caused 
an elevation in TG/HDL-c levels in our study.  
The TG/HDL-c ratio has been proposed as a 
prognostic tool in coronary artery disease 
[6,12].               Moreover, high TG/HDL-c 
levels were associated with abnormal heart rate 
recovery, which is a marker of decreased 
parasympathetic activity and a predictor of all-
cause mortality [13].  
High TG/HDL-c ratio is associated with 
deteriorated insulin sensitivity [14]. Elevated 
TG/HDL-c is suggested to be a predictor of 
incident type 2 diabetes mellitus in male 
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subjects [15]. A similar association between 
diabetes mellitus and increased TG/HDL-c has 
been reported in obese postmenopausal women 
[16]. Since liver steatosis is associated with 
insulin resistance and inflammation, as diabetes 
mellitus do, increased levels of TG/HDL-c in 
patients with liver steatosis is not a coincidental 
finding.  
Retrospective design and moderately large 
study population are two possible limitations of 
our work. However, to the best of our 
knowledge, this is the first study reported high 
sensitivity and specificity of TG/HDL-c ratio in 
detecting liver steatosis.  
In conclusion, we suggest that TG/HDL-c ratio 
could be a useful marker of liver steatosis due 
to its inexpensive and easy to assess nature.  
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